[What significance has the C(2) value in the treatment with cyclosporin A?].
Pham
V V
VV
Institut für klinische Pharmakologie, Universitätsklinikum, Hannover, Germany.
Stichtenoth
D O
DO
Frölich
J C
JC
D000284:Administration, Oral; D001682:Biological Availability; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016903:Drug Monitoring; D004655:Emulsions; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D007275:Injections, Intravenous; D016031:Liver Transplantation; D012016:Reference Values; D012307:Risk Factors; D013997:Time Factors
D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine